You are receiving this email because you opted to receive updates for the page below.
The following materials are updated to reflect the latest ACIP recommendations.
- Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023